| 368865 |
3VHU_model6 |
MM/GBSA |
Completed |
2026-04-20 20:36:31 (UTC + 8 hours) |
| 368864 |
3VHU_model5 |
MM/GBSA |
Completed |
2026-04-20 20:36:31 (UTC + 8 hours) |
| 368863 |
3VHU_model4 |
MM/GBSA |
Completed |
2026-04-20 20:36:31 (UTC + 8 hours) |
| 368862 |
3VHU_model3 |
MM/GBSA |
Completed |
2026-04-20 20:36:31 (UTC + 8 hours) |
| 368861 |
3VHU_model2 |
MM/GBSA |
Completed |
2026-04-20 20:36:31 (UTC + 8 hours) |
| 368860 |
3VHU_model1 |
MM/GBSA |
Completed |
2026-04-20 20:36:31 (UTC + 8 hours) |
| 368859 |
ID984380 |
MM/GBSA |
Completed |
2026-04-20 20:34:18 (UTC + 8 hours) |
| 368858 |
ID151486 |
MM/GBSA |
Completed |
2026-04-20 20:30:57 (UTC + 8 hours) |
| 368857 |
ID003607 |
MM/GBSA |
Completed |
2026-04-20 20:28:39 (UTC + 8 hours) |
| 368856 |
ID954122 |
MM/GBSA |
Completed |
2026-04-20 20:25:09 (UTC + 8 hours) |
| 368855 |
ID502490 |
MM/GBSA |
Completed |
2026-04-20 20:21:57 (UTC + 8 hours) |
| 368854 |
ID872806 |
MM/GBSA |
Completed |
2026-04-20 20:18:22 (UTC + 8 hours) |
| 368853 |
ID348369 |
MM/GBSA |
Completed |
2026-04-20 20:14:44 (UTC + 8 hours) |
| 368852 |
PDL1Atezolizumab2_model10 |
MM/GBSA |
Completed |
2026-04-20 20:12:42 (UTC + 8 hours) |
| 368851 |
PDL1Atezolizumab2_model9 |
MM/GBSA |
Completed |
2026-04-20 20:12:42 (UTC + 8 hours) |
| 368850 |
PDL1Atezolizumab2_model8 |
MM/GBSA |
Completed |
2026-04-20 20:12:42 (UTC + 8 hours) |
| 368849 |
PDL1Atezolizumab2_model7 |
MM/GBSA |
Completed |
2026-04-20 20:12:42 (UTC + 8 hours) |
| 368848 |
PDL1Atezolizumab2_model6 |
MM/GBSA |
Completed |
2026-04-20 20:12:42 (UTC + 8 hours) |
| 368847 |
PDL1Atezolizumab2_model5 |
MM/GBSA |
Completed |
2026-04-20 20:12:42 (UTC + 8 hours) |
| 368846 |
PDL1Atezolizumab2_model4 |
MM/GBSA |
Completed |
2026-04-20 20:12:42 (UTC + 8 hours) |